Full Fed. Circ. Rejects Mylan Rehearing Bid In Patent Case
By Adam Lidgett · July 1, 2025, 8:17 PM EDT
The full Federal Circuit on Tuesday shot down Mylan's request for the court to reconsider a March ruling that the company's planned generic version of schizophrenia drug Invega Trinza would cause...
To view the full article, register now.